New Study in Journal of Tissue Viability Recognizes SEM Scanner Clinical Utility in risk assessment of Pressure Ulcers


New Study in Journal of Tissue Viability Recognizes SEM Scanner’s Clinical Utility in Risk Assessment of Pressure Ulcers

  • Data expands clinical evidence demonstrating SEM Scanner nearly doubles the standard of care for accuracy of pressure ulcer risk assessment
  • Immediate health economic benefits and an increase in patient safety
  • SEM Scanner launched in the UK in 2014 with CE Marking; working with FDA on path toward 2016 US market clearance

View at www.cnn.com

Have questions about our company, products or pipeline? We'd like to hear from you.

Contact us